NCT03329534

Brief Summary

In a small group of people gluten, a storage protein commonly in wheat and other grains, can cause gut inflammation and symptoms like diarrhea and abdominal pain. Gluten-related disorders include celiac disease (CD) and non-celiac gluten sensitivity (NCGS) and are treated by starting a gluten free diet (GFD). Patients with CD and NCGS also more commonly experience esophageal reflux and damage to the lining of the esophagus. A potential consequence of long-standing heartburn is Barrett's esophagus (BE), a major risk factor for cancer of the esophagus. This study aims to investigate the mechanism that leads to reflux and BE in those with gluten related disorders, and to assess if a GFD is beneficial. We will study the upper gut function and reflux activity in patients with BE both with and without a GRD disorder. Testing will occur before and after a gluten free diet is instituted. The results will help inform health care providers and patients about the connection between gluten-related disorders, reflux, BE, and the role of GFD.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2017

Completed
19 days until next milestone

First Posted

Study publicly available on registry

November 6, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

April 1, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2018

Completed
Last Updated

March 21, 2018

Status Verified

October 1, 2017

Enrollment Period

6 months

First QC Date

October 18, 2017

Last Update Submit

March 20, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Ratio of non-acidic to acidic reflux events

    Proportion of non-acid to acid reflux events as determined by pH-impedance

    At study start and at one month after a gluten free diet

Secondary Outcomes (5)

  • Reflux disease questionnaire

    At study start and one month after a gluten free diet

  • Esophageal motility

    At study start

  • Upper gastrointestinal motility

    At study start

  • Leeds short form questionnaire

    At study start and one month after a gluten free diet

  • Gastroesophageal reflux disease-health related quality of life instrument

    At study start and one month after a gluten free diet

Study Arms (2)

Subjects with GRDs

EXPERIMENTAL

An intervention of a change in diet, specifically a gluten free diet taught by a health care professional will be administered for one month's time.

Other: Gluten free diet

Subjects without GRDs

ACTIVE COMPARATOR

An intervention of a change in diet, specifically a gluten free diet taught by a health-care professional will be administered for one month's time.

Other: Gluten free diet

Interventions

A month long gluten free diet

Subjects with GRDsSubjects without GRDs

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years and over
  • Barrett's Esophagus diagnosis based on endoscopy and esophageal biopsies
  • Patients able to comply to the study procedures, according to the investigator's own judgment

You may not qualify if:

  • Patients who have been on a gluten free diet within the last six months
  • History of bariatric surgery, fundoplication, or gastrectomy (partial or complete)
  • Connective tissue disease
  • Concurrent organic GI pathology other than benign polyps, haemorrhoids, lipomas, H. pylori infection, diverticulosis, and melanosis coli
  • Chronic treatment with high dose opioids
  • Alcohol or drug abuse
  • Pregnant or breastfeeding women. Women enrolling in the study will be advised to avoid pregnancy during the course of the study by using adequate birth control such as abstinence, oral contraceptive pill, barrier contraceptives (i.e condom). If a subject becomes pregnant she will be withdrawn from the study.
  • Concurrent systemic disease and/or laboratory abnormalities considered by investigators to be a risk or that could interfere with data collection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Celiac DiseaseBarrett EsophagusGastroesophageal Reflux

Interventions

Diet, Gluten-Free

Condition Hierarchy (Ancestors)

Malabsorption SyndromesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesPrecancerous ConditionsNeoplasmsEsophageal DiseasesEsophageal Motility DisordersDeglutition Disorders

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Premysl Bercik, MD

    McMaster University

    STUDY DIRECTOR

Central Study Contacts

Premysl Bercik, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2017

First Posted

November 6, 2017

Study Start

April 1, 2018

Primary Completion

September 30, 2018

Study Completion

December 30, 2018

Last Updated

March 21, 2018

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share